OQROSign up free
Politician trade (Senate)

CVS Health (CVS): Sen. John Boozman disclosed a purchase $1K–$15K

Sen. John Boozman disclosed a purchase of CVS Health in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
17 days
Disclosure lag
Traded
Jan 29, 2026
Disclosed
Feb 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 23, 2025Insider · Bought outside the usual windowOfficer purchased ~$1.3K of CVS shares in the open market
  2. Nov 21, 2025Congress · 1 personMembers of Congress: 2 sales
  3. Jan 29, 2026 · this disclosureCongressDisclosed purchase of CVS — reported range $1,001 - $15,000

What came next

  1. Feb 10, 2026Company filing · Form 8-K · ResultsReported its results
  2. Mar 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 18, 2026, the Board of Directors (the “Board”) of CVS Health Corporation (“CVS Health” or the “Company”) elected John E. Gallina to serve on the Board, effective March 19, 2026.”
  3. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  4. Mar 31, 2026Government · Federal Register proposed ruleFiduciary Duties in Selecting Designated Investment Alternatives
  5. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  6. May 6, 2026Company filing · Form 8-K · ResultsReported its results
  7. May 8, 2026Insider · 6 days before an 8-KOfficer sold ~$6.23M of CVS shares in the open market
  8. May 14, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 14, 2026, CVS Health Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved the 2026 Incentive Compensation Plan of CVS Health Corporation (the “2026 ICP”), which replaces the Company’s expiring 2017 Incentive Compensation Plan.”
  9. May 19, 2026Insider · 1 personInsiders: 2 sales (~$187.3M)
  10. May 20, 2026Insider · 1 personInsiders: 4 sales (~$95.5M)
  11. May 21, 2026Insider · 1 personInsiders: 2 sales (~$69.9M)
View the official recordSenate eFD periodic transaction report

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for CVS Health

For CVS Health, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CVS page.

Other recent filings by Sen. John Boozman

The full history of Sen. John Boozman is on the profile page.

How this filing works

Explore the data

Other disclosures at CVS Health

Everything OQRO holds on this company is on its CVS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data